ABR-Scan är ett urval av nyligen publicerade nyheter och vetenskapliga artiklar på området antibiotikaresistens och antibiotikaanvändning. Artiklarna väljs ut av Enheten för Antibiotika och Vårdhygien på Folkhälsomyndigheten och har publicerats i olika vetenskapliga tidskrifter.
Observera att de externa länkarna inte är faktakontrollerade. Listan är på inget sätt fullständig och speglar inte nödvändigtvis Stramas åsikter

The publications included in the scan are: Antimicrobial Agents and Chemotherapy, British Medical Journal, Clinical Infectious Diseases, Clinical Microbiology and Infection, Emerging Infectious Diseases, Eurosurveillance, Infection Control & Hospital Epidemiology, Infectious Diseases, JAMA - The Journal of the American Medical Association, Journal of Antimicrobial Chemotherapy, Journal of Hospital Infection, Journal of Infectious Diseases, Lancet, Lancet Infectious Diseases, New England Journal of Medicine, Pediatrics and Scandinavian Journal of Primary Health Care. In addition, other articles from other publications can be included.

ABR-Scan Science week 25-26


First report of an E. coli strain from swine carrying an OXA-181-carbapenemase and colistin resistance determinant MCR-1. International Journal of Antimicrobial Agents

First environmental sample containing plasmid-mediated colistin-resistant ESBL-producing Escherichia coli detected in Norway. APMIS

Global emergence of the widespread Pseudomonas aeruginosa ST235 clone. Clinical Microbiology and Infection

Antibiotic exposure in neonates and early adverse outcomes: a systematic review and meta-analysis. Journal of Antimicrobial Chemotherapy

WGS-based surveillance of third-generation cephalosporin-resistant Escherichia coli from bloodstream infections in Denmark. Journal of Antimicrobial Chemotherapy

Impact of recurrent Clostridium difficile infection: hospitalization and patient quality of life. Journal of Antimicrobial Chemotherapy

Decreased Azithromycin Susceptibility of Neisseria gonorrhoeae Isolates in Patients Recently Treated with Azithromycin. Clinical Infectious Diseases

The first nationwide surveillance of antibacterial susceptibility patterns of pathogens isolated from skin and soft-tissue infections in dermatology departments in Japan. Journal of Infection and Chemotherapy

Epidemiology of pediatric multidrug-resistant tuberculosis in the United States, 1993-2014. Clinical Infectious Diseases

Antimicrobial susceptibility and genotyping of Staphylococcus aureus isolates collected between 1986 and 2015 from ovine mastitis. Veterinary Microbiology

Antibiotic susceptibility profiles among Campylobacter isolates obtained from international travelers between 2007 and 2014. European Journal of Clinical Microbiology & Infectious Diseases

Treatment and diagnosis

Chorioamnionitis and Management of Asymptomatic Infants ≥35 Weeks Without Empiric Antibiotics. Pediatrics

Dose optimization of piperacillin/tazobactam in critically ill children. Journal of Antimicrobial Chemotherapy

The role of Tigecycline in the management of Clostridium difficile infection: a retrospective cohort study. Clinical Microbiology and Infection

Comparative Effectiveness of Cefazolin versus Nafcillin or Oxacillin for Treatment of Methicillin-Susceptible Staphylococcus aureus Infections Complicated by Bacteremia: A Nationwide Cohort Study. Clinical Infectious Diseases

Ceftolozane-Tazobactam for the Treatment of Multidrug-Resistant Pseudomonas aeruginosa Infections: Clinical Effectiveness and Evolution of Resistance. Clinical Infectious Diseases

Short-Course Adjunctive Gentamicin as Empirical Therapy in Patients With Severe Sepsis and Septic Shock: A Prospective Observational Cohort Study. Clinical Infectious Diseases

Prevention and intervention

Management: from antibiotic stewardship to clinical microbiology. Clinical Microbiology and Infection

A mixed-method evaluation of peer-education workshops for school-aged children to teach about antibiotics, microbes and hygiene. Journal of Antimicrobial Chemotherapyd

Sparing carbapenem usage. Journal of Antimicrobial Chemotherapy

Is Antimicrobial Stewardship Cost-Effective? A Narrative Review of the Evidence. Clinical Microbiology and Infection

Outcomes of multisite antimicrobial stewardship programme implementation with a shared clinical decision support system. Journal of Antimicrobial Chemotherapy

Impact of an Integrated Antibiotic Allergy Testing Program on Antimicrobial Stewardship: A Multicenter Evaluation. Clinical Infectious Diseases

Effect of antibiotic stewardship on the incidence of infection and colonisation with antibiotic-resistant bacteria and Clostridium difficile infection: a systematic review and meta-analysis. Lancet Infectious Diseases

Antibiotic stewardship hits a home run for patients. Lancet Infectious Diseases


Prevalences of antimicrobial resistance and the cfiA resistance gene in danish bacteroides fragilis group isolates since 1973. International Journal of Antimicrobial Agents

The emerging metabolic view of Clostridium difficile pathogenesis. Current Opinion in Microbiology

Evaluation of vancomycin MIC Creep in Methicillin resistant Staphylococcus aureus infections – a systematic review and meta-analysis. Clinical Microbiology and Infection

Clinical sensitivity and specificity of the Check-Points Check-Direct ESBL Screen for BD MAX, a real-time PCR for direct ESBL detection from rectal swabs. Journal of Antimicrobial Chemotherapy

A combination of mecillinam and amoxicillin/clavulanate can restore susceptibility of high-level TEM-1-producing Escherichia coli to mecillinam. Journal of Antimicrobial Chemotherapy

Emergence of ceftazidime/avibactam non-susceptibility in an MDR Klebsiella pneumoniae isolate. Journal of Antimicrobial Chemotherapy


Consequence of prioritising pathogens for global antibiotic research. Lancet Infectious Diseases

How artificial is the antibiotic resistance definition? Lancet Infectious Diseases

New and improved? A review of novel antibiotics for Gram-positive bacteria. Clinical Microbiology and Infection

Antibiotic innovation for future public health needs. Clinical Microbiology and Infection

Progress in the Fight Against Multidrug-Resistant Bacteria 2005–2016: Modern Noninferiority Trial Designs Enable Antibiotic Development in Advance of Epidemic Bacterial Resistance. Clinical Infectious Diseases

Contact Precautions for Endemic MRSA and VRE – Time to Retire Legal Mandates. JAMA